Page last updated: 2024-10-30

leflunomide and Myositis, Multiple

leflunomide has been researched along with Myositis, Multiple in 3 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
" We treated a patient who developed polymyositis (PM) following the treatment of RA with leflunomide."7.75Leflunomide-induced polymyositis in a patient with rheumatoid arthritis. ( Nagashima, M; Ochi, S; Taniguchi, K, 2009)
"Leflunomide is a new immunosuppressive drug recently introduced in the treatment of rheumatoid and psoriatic arthritis."5.33Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide. ( Lange, U; Müller-Ladner, U; Piegsa, M; Strunk, J, 2006)
" We treated a patient who developed polymyositis (PM) following the treatment of RA with leflunomide."3.75Leflunomide-induced polymyositis in a patient with rheumatoid arthritis. ( Nagashima, M; Ochi, S; Taniguchi, K, 2009)
"Leflunomide is a new immunosuppressive drug recently introduced in the treatment of rheumatoid and psoriatic arthritis."1.33Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide. ( Lange, U; Müller-Ladner, U; Piegsa, M; Strunk, J, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ochi, S1
Taniguchi, K1
Nagashima, M1
Luca, NJ1
Atkinson, A1
Hawkins, C1
Feldman, BM1
Lange, U1
Piegsa, M1
Müller-Ladner, U1
Strunk, J1

Other Studies

3 other studies available for leflunomide and Myositis, Multiple

ArticleYear
Leflunomide-induced polymyositis in a patient with rheumatoid arthritis.
    Modern rheumatology, 2009, Volume: 19, Issue:4

    Topics: Adjuvants, Immunologic; Alanine Transaminase; Anti-Inflammatory Agents; Antirheumatic Agents; Arthri

2009
Anti-signal recognition particle-positive juvenile polymyositis successfully treated with rituximab.
    The Journal of rheumatology, 2012, Volume: 39, Issue:7

    Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Child; Drug Therapy, Combinati

2012
Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
    Autoimmunity, 2006, Volume: 39, Issue:3

    Topics: Antibodies, Antinuclear; Arthritis; Autoantibodies; Azathioprine; Drug Therapy, Combination; Female;

2006